The package is the product of painstaking negotiations and will give Democrats a chance to achieve major political goals ahead of the upcoming midterm elections.
Once the legislation passes the Senate, it will then need to be approved by the House of Representatives before President Joe Biden can sign it. The House is set to return to consider the legislation this Friday, according to the office of House Majority Leader Steny Hoyer.
In order to pass an invoice through the reconciliation process, however, the package must adhere to a strict set of budget rules. And Republicans are using vote-a-rama to put Democrats on the spot and force politically difficult votes.
As expected, key insulin provisions were removed from the bill after Republicans raised a point of order, prompting a vote to remove them.
The final vote was 57-43. A threshold of 60 votes was needed to keep the provision in place.
Provisions originally included in the bill would have limited insulin prices to $35 per month in the private insurance market as well as through Medicare. But the Senate congressman ruled that the insulin cap on the private insurance market was inconsistent with the reconciliation rules that Democrats use to push their legislation through the House.
Democrats still retained both provisions in the bill, but Republicans raised a point of order to force a vote to remove the private-market-only provisions. Medicare’s $35 insulin cap remains in place.
Meanwhile, Senate Democrats were considering making late changes to the bill’s tax provisions before the chamber’s expected vote on the package on Sunday afternoon, according to Democratic Sen. of West Virginia Joe Manchin. It’s unclear exactly what is being discussed or how significant the changes would be. Manchin suggested Democrats could move an amendment on the floor to reflect those changes.
This story has been updated with additional developments.
CNN’s Manu Raju and Kristin Wilson contributed to this report.